What does the CONVERT trial really tell us about conversion from calcineurin inhibitors to sirolimus? [electronic resource]
Producer: 20090210Description: 164-5 p. digitalISSN:- 1534-6080
- Calcineurin Inhibitors
- Cyclosporine -- administration & dosage
- Drug Therapy, Combination
- Glomerular Filtration Rate -- drug effects
- Graft Rejection -- mortality
- Graft Survival -- drug effects
- Humans
- Immunosuppressive Agents -- administration & dosage
- Kidney Transplantation -- adverse effects
- Randomized Controlled Trials as Topic
- Research Design
- Sirolimus -- administration & dosage
- Tacrolimus -- administration & dosage
- Time Factors
- Transplantation, Homologous
- Treatment Outcome
No physical items for this record
Publication Type: Comment; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.